These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34268431)

  • 1. Decision-support for treatment with
    Moazemi S; Erle A; Khurshid Z; Lütje S; Muders M; Essler M; Schultz T; Bundschuh RA
    Ann Transl Med; 2021 May; 9(9):818. PubMed ID: 34268431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with
    Moazemi S; Erle A; Lütje S; Gaertner FC; Essler M; Bundschuh RA
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics.
    Cao Y; Sutera P; Silva Mendes W; Yousefi B; Hrinivich T; Deek M; Phillips R; Song D; Kiess A; Cem Guler O; Torun N; Reyhan M; Sawant A; Marchionni L; Simone NL; Tran P; Onal C; Ren L
    Radiother Oncol; 2024 Oct; 199():110443. PubMed ID: 39094629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans.
    Erle A; Moazemi S; Lütje S; Essler M; Schultz T; Bundschuh RA
    Tomography; 2021 Jul; 7(3):301-312. PubMed ID: 34449727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Facilitates Hotspot Classification in PSMA-PET/CT with Nuclear Medicine Specialist Accuracy.
    Moazemi S; Khurshid Z; Erle A; Lütje S; Essler M; Schultz T; Bundschuh RA
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32842599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
    Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
    Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based analysis of [
    Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images.
    Du D; Feng H; Lv W; Ashrafinia S; Yuan Q; Wang Q; Yang W; Feng Q; Chen W; Rahmim A; Lu L
    Mol Imaging Biol; 2020 Jun; 22(3):730-738. PubMed ID: 31338709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with
    Yao F; Bian S; Zhu D; Yuan Y; Pan K; Pan Z; Feng X; Tang K; Yang Y
    Radiol Med; 2022 Oct; 127(10):1170-1178. PubMed ID: 36018488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.
    Aksu A; Vural Topuz Ö; Yılmaz G; Çapa Kaya G; Yılmaz B
    Ann Nucl Med; 2022 Mar; 36(3):310-318. PubMed ID: 34988888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 15. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium-68-prostate-specific membrane antigen (
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
    BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study.
    Pan J; Zhang T; Chen S; Bu T; Zhao J; Ni X; Shi B; Gan H; Wei Y; Wang Q; Wang B; Wu J; Song S; Wang F; Liu C; Ye D; Zhu Y
    Ther Adv Med Oncol; 2024; 16():17588359231220506. PubMed ID: 38188464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning for differentiating metastatic and completely responded sclerotic bone lesion in prostate cancer: a retrospective radiomics study.
    Acar E; Leblebici A; Ellidokuz BE; Başbınar Y; Kaya GÇ
    Br J Radiol; 2019 Sep; 92(1101):20190286. PubMed ID: 31219712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Radiomic Models in Prostate Cancer Prognostication.
    Huynh LM; Swanson S; Cima S; Haddadin E; Baine M
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.
    Russo G; Stefano A; Alongi P; Comelli A; Catalfamo B; Mantarro C; Longo C; Altieri R; Certo F; Cosentino S; Sabini MG; Richiusa S; Barbagallo GMV; Ippolito M
    Curr Oncol; 2021 Dec; 28(6):5318-5331. PubMed ID: 34940083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.